Notice of Intent to Publish a Funding Opportunity Announcement for Building Partnerships and Broadening Perspectives to Advance Ethical, Legal and Social Implications (ELSI) Research (UM1), Clinical Trial Optional

Active
Yes
Status
Forecasted
Estimated Post Date
July 19th, 2024
Estimated Close Date
November 15th, 2024
Estimated Award Date
September 1st, 2025
Total Funding
$2,600,000.00
Expected No. Awards
4
Opportunity No.
NOT-HG-24-027

Agency

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Summary

The National Institutes of Health (NIH) plans to publish a Notice of Funding Opportunity (NOFO) for the "Building Partnerships and Broadening Perspectives to Advance Ethical, Legal and Social Implications (ELSI) Research (UM1)" grant. This grant aims to advance scholarship on the ethical, legal, and social implications of advances in human genetics or genomics. It also aims to enhance ELSI research teams, build ELSI research capacity, and broaden the ELSI workforce. The NOFO is expected to be published in the summer of 2024, with an application due date in the fall of 2024. The grant will utilize the UM1 activity code, which is a Research Project with Complex Structure, Cooperative Agreement, Clinical Trial Optional. The estimated total program funding is $2,600,000, and it is expected to award 4 grants. The estimated award date and project start date are both September 1, 2025.

Description

The National Human Genome Research Institute (NHGR) intends to promote a new initiative by publishing a Notice of Funding Opportunity (NOFO) to advance scholarship on the ethical, legal, and social implications (ELSI) of advances in human genetics or genomics, enhance ELSI research teams, build ELSI research capacity, and broaden the ELSI workforce.The intended NOFO will be based on a�concept�recently approved by the National Advisory Council on Human Genome Research and accompanying�discussion. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects, and to consult with NIH following release of the intended NOFO to submit responsive applications.� The NOFO is expected to be published in summer of 2004 with an expected application due date in fall of 2024. This NOFO will utilize the UM1 activity code (Research Project with Complex Structure, Cooperative Agreement, Clinical Trial Optional). Details of the planned NOFO are provided below.

Opportunity Lifecycle

Title
Type
Grant

Similar Opportunities

Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)". This grant is part of the Income Security and Social Services category and falls under the discretionary funding activity. The grant does not require cost sharing or matching. The purpose of this grant is to invite Research Project (R01) applications that propose to study the ethical, legal, and social implications (ELSI) of human genetics and genomics. The grant is open to various types of applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), and U.S. Territory or Possession. The grant supports studies that use either single or mixed methods, including empirical qualitative and quantitative methods, as well as conceptual, legal, and normative analyses. It encourages the direct involvement of key stakeholders where appropriate. Applicants are required to include a Plan for Enhancing Diverse Perspectives (PEDP) as part of their application, as applications without a PEDP will not be reviewed. The close date for this grant opportunity is November 18, 2026, and the archive date is December 24, 2026. For more information and to apply, interested parties can visit the following website: [http://grants.nih.gov/grants/guide/pa-files/PAR-23-293.html](http://grants.nih.gov/grants/guide/pa-files/PAR-23-293.html). For any inquiries, please contact NIH Grants Information at grantsinfo@nih.gov.
Notice of Intent to Publish a Notice of Funding Opportunity Announcement for NINDS Program Project Grant (P01 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) is planning to publish a Notice of Funding Opportunity (NOFO) for the NINDS Program Project Grant (P01 Clinical Trial Optional). This grant aims to support innovative and interactive research that addresses significant scientific questions related to the mission of the National Institute of Neurological Disorders and Stroke (NINDS). The grant encourages collaboration between outstanding scientists who may not typically work together. The program project grant will fund several interdependent projects that offer scientific advantages over individual research grants. The NOFO is expected to be published in April 2024, with application due dates in May and September 2024. After September 2024, no further applications will be accepted, and the program will end. The grant will utilize the P01 activity code.
Notice of Intent to Publish a Funding Opportunity Announcement for Transforming NHGRI�s Diversity Action Plan (R25 Clinical Trials Not Allowed)
National Institutes of Health
The National Institutes of Health (NIH) plans to publish a Funding Opportunity Announcement (FOA) for transforming NHGRI's Diversity Action Plan (R25 Clinical Trials Not Allowed). This initiative aims to enhance workforce diversity in genomics by supporting pathways for individuals from underrepresented groups to pursue a career in genomics. The FOA is expected to be published in Summer 2023, with an application due date in Early 2024. The FOA will utilize the R25 activity code. For more information, contact Lucia A. Hindorff, Ph.D. at hindorffl@mail.nih.gov.
Notice of Intent to Publish a Notice of Funding Opportunity (NOFO) for the Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN)
National Institutes of Health
The National Institutes of Health (NIH) plans to publish a Notice of Funding Opportunity (NOFO) for the Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN). This NOFO aims to solicit applications for research that will advance the diagnosis, management, and treatment of rare diseases. The RDCRC will facilitate collaborative, multi-site, patient-centric, translational, and clinical research. It is encouraged that the RDCRC study outcome measures address unmet clinical trial readiness needs to propel the field of research forward. Potential applicants are provided with sufficient time to develop collaborations and projects. The NOFO is expected to be published in winter 2024, with an application due date in summer 2024. The funding will be in the form of a Cooperative Agreement, and there is no cost sharing or matching requirement. The estimated total program funding is $1,000,000. The NOFO will utilize the U54 activity code, which supports specialized centers through multi-project cooperative agreement awards with substantial involvement from NIH program staff. The estimated synopsis post date is January 24, 2024, and the estimated synopsis close date is June 14, 2024. The estimated award date and project start date are both July 1, 2025.